“…For example, while it has been shown that the downregulation of LOX contributes to the aortic stiffening in an obesity mouse model (Chen et al., 2013), other studies have shown that inhibition of LOX attenuated the angiotensin II induced aortic stiffening (Eberson et al., 2015). In addition, as evidence showed that genetic deletion or functional deficiency of LOX causes aortic wall destruction and leads to aortic stiffening (Lee et al., 2016; Maki et al., 2002; Staiculescu et al., 2017), a smooth muscle cell‐specific overexpression of LOX in a mouse model has been shown to induces arterial stiffness (Martinez‐Revelles et al., 2017). Although the reasons for these inconsistencies are unclear, one potential explanation may arise from the distinct extracellular and intracellular effects of LOX.…”